Currently, the most widely used criteria for assessing response to therapy in high-grade
gliomas are based on two-dimensional tumor measurements on computed tomography (CT) or …

Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable
heterogeneity. We have recently identified recurrent H3F3A mutations affecting two …

Background Standard therapy for newly diagnosed glioblastoma is radiotherapy plus
temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab to …

In response to major changes in diagnostic algorithms and the publication of mature results
from various large clinical trials, the European Association of Neuro-Oncology (EANO) …

Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals,
for instance 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), has been implicated in a variety …

Background Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas are malignant brain
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain-…

This paper aims to provide an overview of the use and assessment of qualitative research
methods in the health sciences. Qualitative research can be defined as the study of the nature …

Somatic mutations in the IDH1 gene encoding cytosolic NADP+-dependent isocitrate
dehydrogenase have been shown in the majority of astrocytomas, oligodendrogliomas and …

Background Radiotherapy is the standard care in elderly patients with malignant astrocytoma
and the role of primary chemotherapy is poorly defined. We did a randomised trial to …